In contrast to anergic T cells, which cannot engage glycolysis even after full activation, our findings demonstrate that both CD4+ and CD8+ T cells from ME/CFS patients are capable of increasing glycolytic activity after activation (Figure 4) [91,145,156,157]. The gene discussed is CD4; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.